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Cerebral perfusion in neurogenic orthostatic hypotension
The excellent overview of neurogenic orthostatic hypotension (OH) by Low and Singer1 is limited in its 
discussion of cerebral perfusion. The authors state that "within a mean blood pressure 
range of 50-150 mm Hg, a change in blood pressure results in an insignificant change in cerebral 
perfusion" and that "patients with OH...have an expansion of the autoregulated range...hence the 
common absence of symptoms".
This section might provide readers with a false impression that they need not worry about the
effects of OH on brain perfusion. The authors' remarks refer to the classic concept of
static autoregulation.2 The stability of cerebral perfusion in this concept applies only to steady-state
situations, such as supine hypertension in patients with orthostatic hypertension. Although Lassen's
classic graph suggested a "plateau-phase" within the blood-pressure range of
50-150 mm Hg, cerebral blood flow actually decreases or increases by about 20%, which is hardly
insignificant.2
Furthermore, when it comes to rapid orthostatic changes in blood pressure, the static autoregulation 
concept is no longer valid. Studies of the dynamic pressure-fl ow association of the cerebral circulation 
have shown that flow changes substantially in response to sudden changes in pressure even if 
autoregulation operates normally.2,3 The study by Novak and colleagues4 illustrates this and shows 
that some patients with OH have impaired rather than improved autoregulation. Because symptoms of 
OH are caused by cerebral hypoperfusion, the interaction between cerebral autoregulation and blood 
pressure determines the clinical consequences, and not the blood pressure itself.
Finally, I am worried about how readers will interpret the advice for "a regimen that relieves 
symptoms...with a supine blood pressure that does not usually exceed 180/110 mm Hg...".
Although the authors acknowledge that supine hypertension is best prevented, the
suggestion that these blood-pressure limits are acceptable is, in my view, at odds with the importantly
increased risks for stroke, heart failure, and mortality associated with these values, certainly in elderly
people.5,6
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